Kodiak Sciences Inc (KOD)
3.60
-0.20
(-5.26%)
USD |
NASDAQ |
May 10, 16:00
3.60
0.00 (0.00%)
After-Hours: 18:23
Kodiak Sciences Cash from Financing (TTM): 0.031M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.031M |
September 30, 2023 | 0.252M |
June 30, 2023 | 0.342M |
March 31, 2023 | 0.226M |
December 31, 2022 | 1.895M |
September 30, 2022 | 3.955M |
June 30, 2022 | 5.908M |
March 31, 2022 | 8.376M |
December 31, 2021 | 8.182M |
September 30, 2021 | 622.31M |
June 30, 2021 | 621.08M |
Date | Value |
---|---|
March 31, 2021 | 619.06M |
December 31, 2020 | 717.38M |
September 30, 2020 | 400.44M |
June 30, 2020 | 399.92M |
March 31, 2020 | 399.43M |
December 31, 2019 | 299.69M |
September 30, 2019 | 85.88M |
June 30, 2019 | 84.54M |
March 31, 2019 | 83.84M |
December 31, 2018 | 116.47M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.031M
Minimum
Dec 2023
717.38M
Maximum
Dec 2020
225.20M
Average
84.54M
Median
Jun 2019
Cash from Financing (TTM) Benchmarks
Avalo Therapeutics Inc | 25.04M |
Regeneron Pharmaceuticals Inc | -1.420B |
iBio Inc | 10.68M |
Puma Biotechnology Inc | 0.00 |
Dare Bioscience Inc | 15.64M |